Literature DB >> 19007614

Progesterone supplementation during the luteal phase and in early pregnancy in the treatment of infertility: an educational bulletin.

.   

Abstract

Exogenous progesterone supplementation is a common element of treatment regimens for infertility, particularly those relating to the assisted reproductive technologies.

Entities:  

Year:  2008        PMID： 19007614     DOI： 10.1016/j.fertnstert.2008.08.064

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  13 in total

Review 1.  Progesterone and the luteal phase: a requisite to reproduction.

Authors:  Tolga B Mesen; Steven L Young
Journal:  Obstet Gynecol Clin North Am       Date:  2015-01-05       Impact factor: 2.844

2.  Progesterone PLGA/mPEG-PLGA Hybrid Nanoparticle Sustained-Release System by Intramuscular Injection.

Authors:  Bin Xie; Yang Liu; Yuting Guo; Enbo Zhang; Chenguang Pu; Haibing He; Tian Yin; Xing Tang
Journal:  Pharm Res       Date:  2018-02-14       Impact factor: 4.200

3.  Luteal phase support for documented failure of placental steroidogenesis: A case report.

Authors:  Bryan Kratz; Amer Rasheed; John P Holden
Journal:  Case Rep Womens Health       Date:  2016-12-22

4.  Systematic Review of Ovarian Activity and Potential for Embryo Formation and Loss during the Use of Hormonal Contraception.

Authors:  Donna Harrison; Cara Buskmiller; Monique Chireau; Lester A Ruppersberger; Patrick P Yeung
Journal:  Linacre Q       Date:  2019-01-03

5.  Comparison of intravaginal progesterone gel and intramuscular 17-α-hydroxyprogesterone caproate in luteal phase support.

Authors:  Funda Satir; Tayfun Toptas; Murat Inel; Munire Erman-Akar; Omur Taskin
Journal:  Exp Ther Med       Date:  2013-04-04       Impact factor: 2.447

6.  Sexual absorption of vaginal progesterone: a randomized control trial.

Authors:  Kathryn S Merriam; Kristina A Leake; Mollie Elliot; Michelle L Matthews; Rebecca S Usadi; Bradley S Hurst
Journal:  Int J Endocrinol       Date:  2015-02-03       Impact factor: 3.257

7.  Thirty-Eight-Year Follow-Up of Two Sibling Lipoid Congenital Adrenal Hyperplasia Patients Due to Homozygous Steroidogenic Acute Regulatory (STARD1) Protein Mutation. Molecular Structure and Modeling of the STARD1 L275P Mutation.

Authors:  Khalil Khoury; Elie Barbar; Youssef Ainmelk; Annie Ouellet; Pierre Lavigne; Jean-Guy LeHoux
Journal:  Front Neurosci       Date:  2016-11-21       Impact factor: 4.677

8.  A questionnaire-based audit to assess overall experience and convenience among patients using vaginal progesterone tablets (Lutigest®) for luteal phase support during IVF treatment.

Authors:  Polly Heine; Laura Sellar; Sue Whitten; Priti Bajaj
Journal:  Patient Relat Outcome Meas       Date:  2017-12-08

9.  A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization.

Authors:  Herman Tournaye; Gennady T Sukhikh; Elke Kahler; Georg Griesinger
Journal:  Hum Reprod       Date:  2017-05-01       Impact factor: 6.918

10.  Detection of early placental hormone production in embryo transfer cycles lacking a corpus luteum.

Authors:  Robert Setton; Kelly McCarter; Lilli D Zimmerman; Zev Rosenwaks; Steven D Spandorfer
Journal:  J Assist Reprod Genet       Date:  2021-01-04       Impact factor: 3.412
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.